PathAI
Matthew Bronnimann is an experienced professional in the field of translational science, currently serving as Associate Director at PathAI since October 2021, where responsibilities include project management for AI-powered digital pathology products and biomarker research in oncology. Prior to this role, Matthew held various positions at Ventana Medical Systems from January 2018 to October 2021, including Senior Translation Science Lead and Senior Scientific Program Manager, contributing to diagnostic assay development and leading a cross-functional group focused on cancer immunotherapy. Earlier academic pursuits included a postdoctoral position at the University of Arizona College of Medicine, researching HIV mechanisms, a PhD in Immunobiology from the University of Arizona, and undergraduate research on Human Papillomavirus entry pathways while earning a Bachelor of Science in Microbiology.
This person is not in any teams
This person is not in any offices
PathAI
59 followers
PathAI's mission is to improve patient outcomes with AI-powered pathology. Their platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.